Blindness News and Research

RSS

Color-deficiency or color-blindness?

Color blindness could be considered a bit of a misleading term, because there are very few people who can't see color at all. Most people have what we call color deficiency or color confusion, which means that they're not blind to color; they just see a reduced number of colors.

From Vision Express 22 Sep 2016

IU receives $1.9 million grant to investigate effects of congenital birth defects and age on the eye

A $1.9 million grant to Indiana University from the National Institutes of Health's National Eye Institute will advance basic research on the eye with applications to blindness caused by genetic disorders and aging.

20 Sep 2016

UAB experts seek to improve patient adherence recommendations for DR screenings

The prevalence of Type 1 and Type 2 diabetes in the United States is 9.3 percent and expected to increase, along with complications associated with diabetes that include diabetic retinopathy, the leading cause of new cases of blindness among adults ages 20 to 74 in the United States.

19 Sep 2016

Researchers identify and treat new variant of antibiotic-resistant E. coli

Researchers at Massachusetts Eye and Ear have discovered a new mutation in a highly antibiotic-resistant strain of E. coli that resists clearance by the body's own immune system by inhibiting white blood cells that ordinarily kill and remove bacteria.

16 Sep 2016

Research findings hold promise for new therapies using proliferating cells to treat patients with FECD

Researchers from Massachusetts Eye and Ear have, for the first time, identified rapidly proliferating cells (known as "neural crest-derived progenitor cells") in the corneal endothelium of specimens from normal corneas and from corneas with Fuchs' Endothelial Corneal Dystrophy (FECD), a condition in which the cells responsible for keeping the cornea clear die prematurely — often leading to blindness.

14 Sep 2016

New funding boosts diabetes research at University of Warwick

Researchers based in the area which suffers the highest rate of type 2 diabetes in Europe are to receive specialist equipment to help them fight the disease.

14 Sep 2016

TKCI pioneers new treatment techniques for patients suffering from Stevens-Johnson syndrome

The Tej Kohli Cornea Institute, in partnership with the world-renowned LV Prasad Eye Institute in Hyderabad, is pioneering new treatments for sufferers of Stevens-Johnson syndrome (SJS), which takes the lives of 20%-25% of the people it affects.

8 Sep 2016

Researchers find genomic material from Zika virus in tears

Researchers have found that Zika virus can live in eyes and have identified genetic material from the virus in tears, according to a study from Washington University School of Medicine in St. Louis.

7 Sep 2016

Study shows link between steroid use and poor outcomes in Lyme disease-associated facial paralysis

Researchers from Massachusetts Eye and Ear/Harvard Medical School have found that patients who were prescribed corticosteroids as part of treatment for Lyme disease-associated facial paralysis had worse long-term outcomes of regaining facial function than those who were prescribed antibiotic therapy alone.

7 Sep 2016

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

The National Institutes of Health will fund six projects to identify biological factors that affect neural regeneration in the retina.

2 Sep 2016

Foul smelling gas could help people with diabetes recover from heart complications

A gas that was formerly known for its noxious qualities could help people with diabetes recover from common heart and blood vessel complications, concludes research led by the University of Exeter Medical School.

1 Sep 2016

Penn scientists find striking similarities between human patients with LCA and dogs

Ciliopathies are diseases that affect the cilia, sensory organelles that most mammalian cells possess and which play a critical role in many biological functions.

30 Aug 2016

Study finds tight glycemic control provides no impact on patient-important microvascular outcomes

The glucocentric focus on lowering blood sugar in Type 2 diabetes may have short-circuited development of new diabetes therapies, according to a new paper published by Mayo Clinic researchers in the journal Circulation: Cardiovascular Quality and Outcomes.

29 Aug 2016

Blindness News and Research

Color-deficiency or color-blindness?

IU receives $1.9 million grant to investigate effects of congenital birth defects and age on the eye

UAB experts seek to improve patient adherence recommendations for DR screenings

Researchers identify and treat new variant of antibiotic-resistant E. coli

Research findings hold promise for new therapies using proliferating cells to treat patients with FECD

New funding boosts diabetes research at University of Warwick

TKCI pioneers new treatment techniques for patients suffering from Stevens-Johnson syndrome

Researchers find genomic material from Zika virus in tears

Study shows link between steroid use and poor outcomes in Lyme disease-associated facial paralysis

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

Foul smelling gas could help people with diabetes recover from heart complications

Penn scientists find striking similarities between human patients with LCA and dogs

Study finds tight glycemic control provides no impact on patient-important microvascular outcomes

Gentle combination of FDA-approved drugs could combat photoreceptor degeneration in mice

Novel drug-dispensing contact lens effective in providing better pressure reduction in glaucoma model

Telemedicine could be more convenient to provide monitoring for diabetic eye care

RPB continues research initiative to address urgent needs in treating low vision

Research opens way towards making promising advances in retinal prostheses

Researcher aims to shed new light on inner workings of the retina

Geographers map internal migration across three continents to help combat infectious diseases

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News